“Data on Favipiravir demonstrates significant improvement in time to clinical cure”

A randomised controlled Phase 3 clinical study by Glenmark Pharmaceuticals found oral antiviral medication Favipiravir, which prevents the replicatio

from The Hindu - Business https://ift.tt/3kRaKOI
via IFTTT